List of works - Pierre Miossec

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

scientific article

A Feedback Loop between Inflammation and Zn Uptake

scientific article published on 4 February 2016

A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis

scientific article published on 08 April 2010

A critical role for immature muscle precursors in myositis ⬇️

scientific article published on March 12, 2013

An update on the cytokine network in rheumatoid arthritis

scientific article published on May 2004

Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium

scientific article (publication date: 15 May 2002)

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

scientific article

Appropriateness of cryoglobulin test request from a sample of 4,963 patients obtained over 5 years. Comment on the Article by Kolopp-Sarda et al

scientific article published on 10 July 2020

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

scientific article published on 22 July 2011

Biomarkers for prediction of TNFalpha blockers response in rheumatoid arthritis

scientific article published on 15 May 2010

Chemokines and dendritic cells in inflammatory myopathies

scientific article published on March 2009

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

scientific article

Classical and Paradoxical Effects of TNF-α on Bone Homeostasis

scientific article published on 13 February 2014

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

scientific article

Cryoglobulins Today: Detection and Immunologic Characteristics of 1,675 Positive Samples From 13,439 Patients Obtained Over Six Years

scientific article published on 20 September 2019

Cytokine response in inflammatory myopathies

scientific article published on August 2007

Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

scientific article published on 14 October 2009

Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis

scientific article

Differential effects of TNF-α and IL-1β on the control of metal metabolism and cadmium-induced cell death in chronic inflammation.

scientific article published on 16 May 2018

Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium

scientific article published on 15 October 2008

Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes

scientific article published on 22 February 2011

High oligoclonality of immunoglobulins in SARS-CoV2 positive patients

scientific article published on 10 August 2020

IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells

scientific article published on 06 June 2019

IL-17 and Th17 cells in human inflammatory diseases

scientific article published on 14 April 2009

IL-17 as a future therapeutic target for rheumatoid arthritis

scientific article

IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

scientific article

IL-17 in Chronic Inflammation: From Discovery to Targeting

scientific article

IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells

scientific article published on June 2007

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

scientific article published on June 2000

IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors

scientific article

IgG subclasses in cryoglobulins: link to composition and clinical manifestations

scientific article published on 12 November 2020

Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis ⬇️

scientific article published on October 17, 2011

Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus

scientific article published on 08 April 2009

Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes

scientific article

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis

scientific article

Interleukin-17 and lupus: enough to be a target? For which patients?

scientific article published on 02 December 2019

Interleukin-17 and type 17 helper T cells

scientific article

Interleukin-17 in Inflammatory Myopathies ⬇️

scientific article published on June 1, 2012

Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified

scientific article published on July 2007

Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy

scientific article

Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis

scientific article published on 7 December 2012

Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment

scientific article published in July 2006

Physiopathology of haemophilic arthropathy

scientific article published on July 2008

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.

scientific article published on December 2008

Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis

scientific article

Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes

scientific article

Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis

scientific article

Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation

scientific article published on 25 July 2017

Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope

scientific article published on 26 October 2006

Rheumatoid arthritis in 2013. Translational medicine in RA: time for change

scientific article published on 14 January 2014

Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression

scientific article

Synergistic effect of interleukin-17 and tumor necrosis factor-α on inflammatory response in hepatocytes through interleukin-6 dependent and independent pathways.

scientific article published on 20 April 2018

Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors?

scientific article published on 28 July 2020

Systemic effects of IL-17 in inflammatory arthritis

scientific article published on 21 June 2019

Targeting IL-17 and TH17 cells in chronic inflammation

scientific article published on October 2012

Th17 and regulatory T cell balance in autoimmune and inflammatory diseases

scientific article published on 11 January 2014

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

scientific article published on 26 May 2012

The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis

scientific article published on 24 September 2019

The role of T cells in rheumatoid arthritis: new subsets and new targets

scientific article published on May 2007

The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

scientific article published on 11 August 2005

Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions.

scientific article

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

scientific article published on 11 May 2020

Zinc and its role in immunity and inflammation

scientific article

List of works by Pierre Miossec

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

A Feedback Loop between Inflammation and Zn Uptake

A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis

A critical role for immature muscle precursors in myositis ⬇️

An update on the cytokine network in rheumatoid arthritis

Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

Appropriateness of cryoglobulin test request from a sample of 4,963 patients obtained over 5 years. Comment on the Article by Kolopp-Sarda et al

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Biomarkers for prediction of TNFalpha blockers response in rheumatoid arthritis

Chemokines and dendritic cells in inflammatory myopathies

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

Classical and Paradoxical Effects of TNF-α on Bone Homeostasis

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

Cryoglobulins Today: Detection and Immunologic Characteristics of 1,675 Positive Samples From 13,439 Patients Obtained Over Six Years

Cytokine response in inflammatory myopathies

Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis

Differential effects of TNF-α and IL-1β on the control of metal metabolism and cadmium-induced cell death in chronic inflammation.

Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium

Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes

High oligoclonality of immunoglobulins in SARS-CoV2 positive patients

IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells

IL-17 and Th17 cells in human inflammatory diseases

IL-17 as a future therapeutic target for rheumatoid arthritis

IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

IL-17 in Chronic Inflammation: From Discovery to Targeting

IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors

IgG subclasses in cryoglobulins: link to composition and clinical manifestations

Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis ⬇️

Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus

Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis

Interleukin-17 and lupus: enough to be a target? For which patients?

Interleukin-17 and type 17 helper T cells

Interleukin-17 in Inflammatory Myopathies ⬇️

Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified

Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy

Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis

Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment

Physiopathology of haemophilic arthropathy

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.

Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis

Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes

Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis

Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation

Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope

Rheumatoid arthritis in 2013. Translational medicine in RA: time for change

Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression

Synergistic effect of interleukin-17 and tumor necrosis factor-α on inflammatory response in hepatocytes through interleukin-6 dependent and independent pathways.

Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors?

Systemic effects of IL-17 in inflammatory arthritis

Targeting IL-17 and TH17 cells in chronic inflammation

Th17 and regulatory T cell balance in autoimmune and inflammatory diseases

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis

The role of T cells in rheumatoid arthritis: new subsets and new targets

The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Zinc and its role in immunity and inflammation